Thank you for signing up to the VHH Newsletter!
Before you can receive our news and updates about our VHH research, you need to confirm your subscription (It’s easy). Just go to your email and click the link we sent you.
The Isogenica team.
About Isogenica
Isogenica is a biotechnology contract research organisation (CRO) specialised in small-format antibody discovery.
In particular, we focus on VHH – single-domain antibodies that offer exceptional robustness, flexibility, and scalability across varied therapeutic and diagnostic applications.
Combining the largest and most diverse synthetic VHH libraries available with our proprietary, cell-free CIS display technology means that these uniquely vast libraries can reach their full potential.
Our expert scientists tailor-make each project, allowing us to provide industry-disrupting antibody solutions to partners in around half the time of a traditional animal immunisation campaign.
Follow us
Follow us on Linkedin
Or sign up to our Newsletter